TNF and Alzheimer disease: Like TNF, reductions in sTNFR2 significantly associated with improvement in AD as measured by SCORing Atopic Dermatitis (SCORAD) metric (a metric which combines clinical scores for itch, rash, and sleep disturbance) (Figure 1H).